Pfizer
PFE
PFE
2,897 hedge funds and large institutions have $105B invested in Pfizer in 2026 Q1 according to their latest regulatory filings, with 246 funds opening new positions, 1,281 increasing their positions, 1,071 reducing their positions, and 169 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
13% more capital invested
Capital invested by funds: $92.9B → $105B (+$12B)
0.12% more ownership
Funds ownership: 65.66% → 65.78% (+0.12%)
0% more funds holding
Funds holding: 2,895 → 2,897 (+2)
Holders
2,897
Holding in Top 10
45
Calls
$3.08B
Puts
$2.68B
Top Buyers
| 1 | +$1.41B | |
| 2 | +$241M | |
| 3 | +$188M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$176M |
| 5 |
Bank of New York Mellon
New York
|
+$143M |
Top Sellers
| 1 | -$403M | |
| 2 | -$176M | |
| 3 | -$166M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$148M |
| 5 |
Corient Private Wealth
Miami,
Florida
|
-$145M |
